- Joseph Dziedzic to retire as CEO of Integer Holdings (ITGR, Financial) on October 24, 2025.
- Payman Khales, the current COO, will succeed Dziedzic as President and CEO.
- Dziedzic will remain as an advisor until March 31, 2026, to ensure a smooth transition.
Integer Holdings Corporation (ITGR), a leading medical device contract manufacturer, has announced a leadership transition effective October 24, 2025. Joseph Dziedzic, the current President and CEO, will retire and be succeeded by Payman Khales, who currently serves as Chief Operating Officer.
Under Dziedzic's eight-year leadership, Integer has focused on high-growth markets and invested in differentiated technologies, contributing to significant company growth. His tenure also saw the implementation of the Integer Production System, enhancing manufacturing consistency and operational excellence.
Payman Khales, who joined Integer in 2018 as President of the Cardio & Vascular business unit, is credited with doubling the division's sales over seven years, achieving above-market growth. As COO, Khales has overseen both the Cardio & Vascular and the Cardiac Rhythm Management & Neuromodulation business units, alongside global operations and manufacturing strategy.
To ensure a seamless transition, Dziedzic will continue to serve as an advisor through March 31, 2026. This carefully planned succession is aligned with corporate governance best practices, ensuring leadership continuity during this period of strong company performance.
The Integer Board has expressed satisfaction with the company's current trajectory, noting its success in delivering above-market organic sales growth with expanding margins. This leadership change is seen as a continuity move rather than a strategic shift, maintaining the positive momentum within the organization.
